Earth Science Tech, Inc. (OTC:ETST) Submission of Form 10 to Become Fully Reporting Signifies OTCQB Uplisting

Earth Science Tech, Inc. (OTC:ETST) Submission of Form 10 to Become Fully Reporting Signifies OTCQB Uplisting

June 3, 2018 (PENNY STOCK WIRE) — via NetworkWire – Earth Science Tech, Inc. (OTC:ETST) (“ETST” or the “Company”), a biotech company focused on the cannabidiol (CBD) market, has signified its intentions to uplist based on its completion of the audit as well as the Form 10 submission to become fully reporting.

“Earth Science Tech, Inc., is pleased to announce that the audit process has been finalized and the Company has submitted Form 10 to become fully reporting.”

The Company’s CEO and Chief Science Officer, Dr. Michel Aube, states,

“I am very proud of the hard work done by our team to complete the audits. These efforts will be rewarded by the positive reception of our current and future investors. Transparency is a key tool that we needed to accelerate the growth of our business. Since all of our amazing projects are ongoing with our partners, investor confidence will grow, and we will be able to complete our first big round of financing. We are in touch with institutional and private investors that were waiting for ETST to become a fully reporting company before investing the necessary amount to commercialize our projects. We can now resume our discussions with them.”

This comes at an interesting time for the company, as they recently signed an agreement to work collectively with AATAC to present the “ETST” product line to their vast network of approximately 90,000 retail outlets throughout the U.S.

The Company’s Chief Sales Officer, Jill Buzan  stated,

“Our association with AATEC which is an advisory board that focuses on convenience stores will give us the opportunity to open up and be available to a market that includes every  sector of the population. This could lead to huge exponential growth for ETST’s sales in the next few months.”

More recently, ETST has expanded it lines, along with new CBD full spectrum products designed for animals. The company is expecting significant growth over the short term, with major expansion and partnerships planned for the long term. The Company plans to share further updates on the launch date of the three new chocolate products, research and development, Form 10 approval, and medical device updates as each  progresses.


Leave a Reply

Your email address will not be published. Required fields are marked *